Ani Labsystems has updated the well-recognized Toxoplasma gondii IgG Avidity EIA test, originally the first Toxoplasma avidity test in the world.  New T. gondii IgM EIA and IgG EIA tests are also being developed to form a full Toxo package.

The new T. gondii IgM EIA is a microcapture test, that can be run simultaneously with the new T. gondii IgG EIA. The latter provides quantitative results, and generates automatically the guidelines for the avidity assay (only 2 points dilution). Generally, the reliability of the original avidity test is now combined within a full package of tests that can be run fully automated as well as manually.

For neonatal screening Ani Labsystems currently offers Neonatal Toxoplasma gondii IgM FEIA. The photometric version, Neonatal Toxoplasma gondii IgM EIA, has recently been clinically evaluated, with over 1000 patient samples and almost 300 CDC samples, to have excellent specificity and sensitivity.